Autres langues Invex Therapeutics Ltd

Actions

IXC

AU0000048621

Marché Fermé - Australian S.E. Autres places de cotation 04:26:51 08/05/2024			Varia. 5j.	Varia. 1 janv.
0,078 ^AUD	-7,14%		-2,50%	-3,70%

16/02	Invex Therapeutics réduit la perte du premier semestre fiscal grâce à la baisse des dépenses de R&D	MT
15/02	Invex Therapeutics Ltd publie ses résultats pour le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Australia's Tax Agency Publishes Ruling on Invex Therapeutics' Capital Return	20/03
Invex Therapeutics Narrows Fiscal H1 Loss on Lower R&D Expenses	16/02
Invex Therapeutics Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	15/02
Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal	22/12
Invex Therapeutics to Secure European Patent Grant for Neurological Medication	22/11
Invex Therapeutics Ltd Announces Appointment of David Wheeler as Non-Executive Director	08/11
Invex Therapeutics Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	17/08/23
Invex Therapeutics Ltd Announces Board Changes	03/07/23
Invex Therapeutics Jumps 19% After Securing Second European Orphan Drug Designation for Exenatide	23/06/23
Invex Therapeutics Secures Approval for IIH EVOLVE Phase III Trial in France; Shares Rise 7%	21/04/23
Israel's Ministry of Health Approves Invex Therapeutics' IIH EVOLVE Clinical Trial	20/04/23
Invex Therapeutics Secures Clearance for Phase 2 Neurological Trial in Germany; Shares Rise 4%	20/03/23
Invex Therapeutics Ltd Announces the Approval to Commence the IIH EVOLVE Phase III Clinical Trial	19/03/23
Invex Therapeutics Ltd. Announces the Publication of the Invex Phase II 'Pressure' Clinical Trial	13/03/23
Invex Therapeutics More Than Doubles Fiscal H1 Loss	17/02/23
Invex Therapeutics Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	16/02/23
Invex Therapeutics Opens First US Clinical Trial Site in Texas	19/01/23
Invex Therapeutics Ltd Announces First US Clinical Site Activated in IIH Evolve Phase III Clinical Trial	18/01/23
Invex Therapeutics Gains European Regulator Approval for Pediatric Plan	14/12/22
Invex Therapeutics Ltd Receives Approval for Paediatric Plan from the EMA	13/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Invex Therapeutics Ltd

Actions

IXC

AU0000048621

Autres langues

Filtres